Blog

Global science-led UK healthcare company GlaxoSmithKline (GSK) has announced a new manufacturing agreement with our healthcare subsidiary, Bioventure Healthcare FZE (previously known as Geltec Healthcare FZE). Through this venture, GSK will transfer to the UAE the secondary packaging of 20 of its key products across several therapy areas, including the central nervous system, dermatology, urology,...

GlobalOne Healthcare Holding (GHH), our Healthcare Division, announced the rebranding of its subsidiary Geltec Healthcare FZE as Bioventure Healthcare FZE, as part of its strategy to strengthen its business and drive growth in the pharmaceutical and supplement manufacturing industry. A strategic partner of multi-national companies and a key exporter to the U.S., Bioventure Healthcare FZE...